Early Tobacco Abstinence - 5
Early Tobacco Abstinence in High Risk Smokers
2 other identifiers
interventional
140
1 country
1
Brief Summary
This proposal will conduct a prospective examination of the clinical course (intensity, content and duration) of tobacco (nicotine) abstinence effects in male and female smokers who are either heavy/light alcohol drinkers with/without depressive symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Completion
Last participant's last visit for all outcomes
October 1, 2004
CompletedFirst Submitted
Initial submission to the registry
September 22, 2005
CompletedFirst Posted
Study publicly available on registry
September 23, 2005
CompletedJanuary 12, 2017
September 1, 2005
September 22, 2005
January 11, 2017
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- \) between ages 18-60 years; (2) able to read and write English (3) SMOKER: Smoking \>10 cigarettes per day for at least 1 year, with CO \> 10 ppm, and blood cotinine concentration of 150 ng/ml or greater, FTND scores \> 5.
- (4) DEPRESSED SUBJECT: Not meeting SCID criteria for current major depression or more than one past major depressive episode, but having scores \> 10 on the CES-D indicating presence of depressive symptomatology (5) NON-DEPRESSED SUBJECT: Not meeting SCID criteria for current major depression or more than one past major depressive episode, CES-D scores \<10.
- (6) HEAVY DRINKER: Not meeting SCID criteria for current alcohol dependence; drinking 20 or more drinks per month.
- (7) LIGHT DRINKER: Not meeting SCID criteria for current alcohol dependence; drinking ten drinks or less per month
You may not qualify if:
- Current dependence on cocaine, marijuana, opiates or alcohol
- Positive urine screen for marijuana, cocaine or opiates at any appointment after the intake appointment.
- Regular use of any psychoactive drugs including anxiolytics and antidepressants;
- Current major depression or other psychiatric conditions
- Subjects with any significant, untreated current medical conditions condition such as neurological, endocrine, cardiovascular, renal, liver, thyroid pathology or on medications for any recent medical events 6) Pregnant or lactating women -
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yale University, Dept. of Psychiatry
Minneapolis, Minnesota, 55415, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stephanie O'Malley, Ph.D.
Substance Abuse Treatment Unit
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- NIH
Study Record Dates
First Submitted
September 22, 2005
First Posted
September 23, 2005
Study Completion
October 1, 2004
Last Updated
January 12, 2017
Record last verified: 2005-09